Clinical trial
Efficacy and Safety of Painless 5-aminolevulinic Acid Photodynamic Therapy for the Treatment of Moderate and Severe Acne Vulgaris-- A Multi-center, Randomized Controlled Clinical Trial
NCT04167982 is registered in ClinicalTrials.gov with Shanghai Dermatology Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Painless 5-aminolevulinic Acid Photodynamic Therapy for the Treatment of Moderate and Severe Acne Vulgaris-- A Multi-center, Randomized Controlled Clinical Trial
- Lead sponsor
- Shanghai Dermatology Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 28, 2020
- Completion date
- November 30, 2022
- Enrollment
- 234 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acne